Type 2 diabetes : cardiovascular and related complications and evidence-based complementary treatments
Publication details: Boca Raton ; London : CRC Press, 2019Description: xxvii, 481pISBN:- 9781138580565
- WK 835.
Item type | Home library | Class number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|
Book | PRUH Education Centre Library Shelves | WK 835 (Browse shelf(Opens below)) | Available | B04509 | ||
Book | Queen's Hospital Jackie Blanks Library Shelves | WK 815 (Browse shelf(Opens below)) | Available | T10863 |
Browsing PRUH Education Centre Library shelves, Shelving location: Shelves Close shelf browser (Hides shelf browser)
Approximately 29 million Americans are diagnosed with Type 2 diabetes annually. Of that number, only about 36 percent (10.44 million diabetes sufferers) achieve satisfactory medical outcomes and would need additional help-rarely available-to reliably control their glucose levels. Contrary to popular belief, although anti-diabetic medications can lower sugar levels, nevertheless they have a poor performance track record because inflammation in the blood vessels persists. This book details recent scientific findings that cardiovascular, kidney, vision, peripheral nervous system, and other body damage caused by chronic high levels of blood sugar (hyperglycemia) in Type 2 diabetes is actually due to excessive generation of unopposed free radicals and reactive oxygen species (ROS). These, in turn, cause chronic systemic inflammation and dysfunction of the endothelial lining of the arterial blood vessels, jeopardizing the formation of the protective molecule nitric oxide (NO), thus severely impairing the blood supply to every organ and tissue in the body. This book also catalogues the evidence that chronic hyperglycemia causes profound and often irreversible damage-even long before Type 2 diabetes has been diagnosed. In addition, because conventional prescription treatments are, unfortunately, often inadequate, the book details evidence-based complementary means of blood sugar control.
There are no comments on this title.